Catalyst
Slingshot members are tracking this event:
BioPharmX Corporation (BPMX) looking to commence phase 3 trial on acne vulgaris treatment BPX-01 in 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| BPMX | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 01, 2017
Occurred Source:
http://biopharmx.investorroom.com/2017-06-01-BioPharmX-Advances-BPX-01-2-Upon-Achieving-Statistical-Significance-for-Primary-Endpoint
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 3, Bpx-01, Acne Vulgaris
